ichrogene

BiotechnologySeries AGyeonggi-do, South Koreaichrogene.co.kr

Latest round

Series A

Last raised

May 2021

Total raised

$2.7M

Investors

1

About ichrogene

Based in Yeongtong-gu, South Korea, and founded in 2017, ichrogene Inc operates as a biotechnology company that develops gene big data analysis services which are used to treat chronic disease and cancer. In May 2021, ichrogene, Inc. The company offers a gene type data analysis comprehensive platform which provides genome analysis and offers predicting services for chronic diseases, cancer, personal characteristics, etc. through genomic big data analysis. The platform is known as iGAPonCloud. It also provides iDNADoctor which is a genetic testing service, iSearchme which is a raw DBA data uploading service, and iCareMe which is an application-based health information provider.

Who invested in ichrogene

1 investor across 1 round

See all investors in ichrogene

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    May 3, 2021

    Amount

    $2.7M

    Investors

    Locked

Questions about ichrogene

Who invested in ichrogene?

ichrogene has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ichrogene raised?

ichrogene has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did ichrogene last raise money?

ichrogene's most recent round on record is a Series A, in May 2021.

What does ichrogene do?

Based in Yeongtong-gu, South Korea, and founded in 2017, ichrogene Inc operates as a biotechnology company that develops gene big data analysis services which are used to treat chronic disease and cancer.

Where is ichrogene headquartered?

ichrogene is headquartered in Gyeonggi-do, South Korea.

Which VCs invest in companies like ichrogene?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ichrogene's stage. Their profiles are linked below.

Raising like ichrogene? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.